Patients with Crohn’s disease maintained steroid-free remission for three years with Lilly’s Omvoh (mirikizumab-mrkz) PR NewswireEdward Barnes, MD, MPH HCPLiveCrohn’s patients stayed steroid-free 3 years on Eli Lilly’s Omvoh Stock Titan3-Year Efficacy, Safety of Mirikizumab in Crohn’s Disease: Insights From VIVID-2, With Edward Barnes, MD, MPH HCPLive